<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="105414-2018"
            EDITION="2018048">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-109689-001</RECEPTION_ID>
      <DELETION_DATE>20180616</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>48</NO_OJ>
         <DATE_PUB>20180309</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 048-105414</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:105414-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="UK"/>
         <IA_URL_GENERAL>http://www.nhsscotlandprocurement.scot.nhs.uk/</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33651660">Influenza vaccines</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="UK">UNITED KINGDOM</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="UKM">SCOTLAND</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="UK">UNITED KINGDOM</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="GBP">4773000</VALUE>
         </VALUES>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180308</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="3">Regional or local authority</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="V">Voluntary ex ante transparency notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B15</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Обединено кралство</TI_CY>
            <TI_TOWN>Единбург</TI_TOWN>
            <TI_TEXT>
               <P>Противогрипни ваксини</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Spojené království/Velká Británie</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Očkovací látka proti chřipce</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Forenede Kongerige, Det</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Influenzavacciner</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>das Vereinigte Königreich</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Anti-Grippe-Impfstoffe</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ηνωμένο Βασίλειο</TI_CY>
            <TI_TOWN>Εδιμβούργο</TI_TOWN>
            <TI_TEXT>
               <P>Αντιγριππικά εμβόλια</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>United Kingdom</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Influenza vaccines</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Vacunas contra la gripe</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Suurbritannia / Ühendkuningriik</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Gripivastased vaktsiinid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Yhdistynyt kuningaskunta</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Influenssarokotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Royaume-Uni</TI_CY>
            <TI_TOWN>Édimbourg</TI_TOWN>
            <TI_TEXT>
               <P>Vaccins antigrippe</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Ríocht Aontaithe, an</TI_CY>
            <TI_TOWN>Dún Éideann</TI_TOWN>
            <TI_TEXT>
               <P>Influenza vaccines</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Ujedinjena Kraljevina</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Cjepiva protiv gripe</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Egyesült Királyság</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Influenzavakcinák</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Regno Unito</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Vaccini antinfluenzali</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Jungtinė Karalystė, Didžioji Britanija</TI_CY>
            <TI_TOWN>Edinburgas</TI_TOWN>
            <TI_TEXT>
               <P>Gripo vakcinos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Apvienotā Karaliste</TI_CY>
            <TI_TOWN>Edinburga</TI_TOWN>
            <TI_TEXT>
               <P>Gripas vakcīnas</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Ir-Renju Unit</TI_CY>
            <TI_TOWN>Edinbugh</TI_TOWN>
            <TI_TEXT>
               <P>Vaċċini ta' l-influwenza</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Verenigd Koninkrijk</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Griepvaccins</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Zjednoczone Królestwo</TI_CY>
            <TI_TOWN>Edynburg</TI_TOWN>
            <TI_TEXT>
               <P>Sczepionki przeciw grypie</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Edimburgo</TI_TOWN>
            <TI_TEXT>
               <P>Vacinas antigripe</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Regatul Unit</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Vaccinuri antigripale</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Spojené kráľovstvo</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Očkovacie látky proti chrípke</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Združeno kraljestvo</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Cepiva proti gripi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Förenade kungariket</TI_CY>
            <TI_TOWN>Edinburgh</TI_TOWN>
            <TI_TEXT>
               <P>Influensavaccin</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <NOTICE_UUID>0ca950d6-6830-475b-af0a-d34ec1bccaab</NOTICE_UUID>
      <F15_2014 CATEGORY="ORIGINAL" FORM="F15" LG="EN">
         <DIRECTIVE VALUE="2014/24/EU"/>
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")</OFFICIALNAME>
               <ADDRESS>Gyle Square (NSS Head Office), 1 South Gyle Crescent</ADDRESS>
               <TOWN>Edinburgh</TOWN>
               <POSTAL_CODE>EH12 9EB</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <CONTACT_POINT>Laura Ferguson</CONTACT_POINT>
               <PHONE>+44 1698794410</PHONE>
               <E_MAIL>lauraferguson1@nhs.net</E_MAIL>
               <n2016:NUTS CODE="UKM"/>
               <URL_GENERAL>http://www.nhsscotlandprocurement.scot.nhs.uk/</URL_GENERAL>
               <URL_BUYER>http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="REGIONAL_AUTHORITY"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Adjuvanted Trivalent Influenza Vaccine (Fluad)</P>
            </TITLE>
            <REFERENCE_NUMBER>NP93813(a)</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33651660"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>This contract is for the supply of adjuvanted trivalent influenza vaccines (Fluad) for use in the NHS Scotland 2018/19 Seasonal Influenza Immunisation Programme.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="GBP">4773000</VAL_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33651660"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UK"/>
               <MAIN_SITE>
                  <P>Delivery should be made to OM Movianto, Unit H3, Deacon Park, Knowsley Industrial Park, Liverpool, L33 7RX.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>This procurement is for the supply of adjuvanted trivalent influenza vaccine (Fluad) for use in the annual seasonal influenza immunisation programme in General Practices and Hospitals across NHS Scotland.</P>
               </SHORT_DESCR>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <DIRECTIVE_2014_24_EU>
               <PT_NEGOTIATED_WITHOUT_PUBLICATION>
                  <D_ACCORDANCE_ARTICLE>
                     <D_TECHNICAL/>
                  </D_ACCORDANCE_ARTICLE>
                  <D_JUSTIFICATION>
                     <P>Seqirus Vaccines Ltd are currently the sole supplier of adjuvanted trivalent influenza vaccine for which no direct competition exists.</P>
                  </D_JUSTIFICATION>
               </PT_NEGOTIATED_WITHOUT_PUBLICATION>
            </DIRECTIVE_2014_24_EU>
            <CONTRACT_COVERED_GPA/>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>NP93818(a)</CONTRACT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-07</DATE_CONCLUSION_CONTRACT>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Seqirus Vaccines Limited</OFFICIALNAME>
                     <ADDRESS>Gaskill Road, Speke</ADDRESS>
                     <TOWN>Liverpool</TOWN>
                     <POSTAL_CODE>L24 9GR</POSTAL_CODE>
                     <COUNTRY VALUE="UK"/>
                     <PHONE>+44 1517055677</PHONE>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="GBP">4773000</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>The total value in Section II.1.7 and V.2.4 refers to the twelve (12) month duration of the contract.</P>
               <P>(SC Ref:533275).</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")</OFFICIALNAME>
               <ADDRESS>Gyle Square (NSS Head Office), 1 South Gyle Crescent</ADDRESS>
               <TOWN>Edinburgh</TOWN>
               <POSTAL_CODE>EH12 9EB</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <PHONE>+44 1698794410</PHONE>
               <URL>http://www.nhsscotlandprocurement.scot.nhs.uk/</URL>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>The notification will incorporate a “standstill period” of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer. The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-03-08</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F15_2014>
   </FORM_SECTION>
</TED_EXPORT>
